
GC68776
BLU2864
Also known as N-[(1R,2S)-5-(difluoromethyl)-7-fluoro-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-6-(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)pyridine-3-carboxamide
BLU2864 is an orally active, highly selective, ATP-competitive inhibitor of PRKACA (IC50=0·3 nM)· BLU2864 has anti-tumor activity and can be used for research on cancer and polycystic kidney disease
ChemicalCAS2810747-89-6MW452.43FormulaC24H19F3N4O2
- CAS number
- 2810747-89-6
- Molecular weight
- 452.43
- Formula
- C24H19F3N4O2
- Solubility
- DMSO : 100 mg/mL (221·03 mM; Need ultrasonic)
- InChIKey
- VRPOVDLLZCQZEG-RXVVDRJESA-N
- Catalogue number
- GC68776
- Brand
- GLPBIO
Computed properties PubChem CID 164603354 · XLogP 3.2 · TPSA 90.9 Ų · H-bond donors 3
- XLogP
- 3.2
- TPSA
- 90.9 Ų
- H-bond donors
- 3
- H-bond acceptors
- 7
- Rotatable bonds
- 4
- Heavy atoms
- 33
SMILES CC1=CNC2=NC=CC(=C12)C3=NC=C(C=C3)C(=O)N[C@H]4[C@H](CC5=C4C(=CC(=C5)C(F)F)F)O
Computed descriptors from PubChem (CID 164603354), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il